Medium

  • US 20030068306A1
  • Filed: 09/13/2002
  • Published: 04/10/2003
  • Est. Priority Date: 09/14/2001
  • Status: Abandoned Application
First Claim
Patent Images

1. Medium for expanding natural killer cells expressing the CD56+CD3

  • phenotype, comprising CellGro®

    SCGM to which has been added interleukin-2 and anti CD3 antibodies.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×